Found: 40
Select item for more details and to access through your institution.
Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2004, v. 20, n. 1, p. 55, doi. 10.1002/dmrr.419
- By:
- Publication type:
- Article
Safety and tolerability of exenatide once weekly in patients with type 2 diabetes: an integrated analysis of 4,328 patients.
- Published in:
- Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2015, v. 8, p. 241, doi. 10.2147/DMSO.S77290
- By:
- Publication type:
- Article
Metabolic effects of the incretin mimetic exenatide in the treatment of type 2 diabetes.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Properties of pramlintide and insulin upon mixing.
- Published in:
- American Journal of Health-System Pharmacy, 2005, v. 62, n. 8, p. 816, doi. 10.1093/ajhp/62.8.816
- By:
- Publication type:
- Article
Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus.
- Published in:
- American Journal of Health-System Pharmacy, 2005, v. 62, n. 2, p. 173., doi. 10.1093/ajhp/62.2.173
- By:
- Publication type:
- Article
Synthetic Exendin-4 (Exenatide) Significantly Reduces Postprandial and Fasting Plasma Glucose in Subjects with Type 2 Diabetes.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2003, v. 88, n. 7, p. 3082, doi. 10.1210/jc.2002-021545
- By:
- Publication type:
- Article
Relationship between serum glucose level and the metabolic clearance rate of glucose in non-insulin-dependent diabetes mellitus.
- Published in:
- 1983
- By:
- Publication type:
- journal article
Defect in glucose removal in nonketotic diabetic patients with fasting hyperglycemia.
- Published in:
- 1979
- By:
- Publication type:
- journal article
Effect of Adjunctive Pramlintide Treatment on Treatment Satisfaction in Patients With Type 1 Diabetes.
- Published in:
- Diabetes Care, 2007, v. 30, n. 2, p. 210, doi. 10.2337/dc06-1026
- By:
- Publication type:
- Article
A Double-Blind, Placebo-Controlled Trial Assessing Pramlintide Treatment in the Setting of Intensive Insulin Therapy in Type 1 Diabetes.
- Published in:
- Diabetes Care, 2006, v. 29, n. 10, p. 2189, doi. 10.2337/dc06-0042
- By:
- Publication type:
- Article
Closing the Gap: Effect of Diabetes Case Management on Glycemic Control Among Low-Income Ethnic Minority Populations.
- Published in:
- Diabetes Care, 2004, v. 27, n. 1, p. 95, doi. 10.2337/diacare.27.1.95
- By:
- Publication type:
- Article
Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes: a dose-timing study.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagon, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps.
- Published in:
- 2003
- By:
- Publication type:
- journal article
A Randomized Study and Open-Label Extension Evaluating the Long-Term Efficacy of Pramlintide as an Adjunct to Insulin Therapy in Type 1 Diabetes.
- Published in:
- Diabetes Care, 2002, v. 25, n. 4, p. 724, doi. 10.2337/diacare.25.4.724
- By:
- Publication type:
- Article
Pramlintide, a synthetic analog of human amylin, improves the metabolic profile of patients with type 2 diabetes using insulin. The Pramlintide in Type 2 Diabetes Group.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Empirical Validation for a Family-Centered Model of Care.
- Published in:
- Diabetes Care, 1995, v. 18, n. 10, p. 1347, doi. 10.2337/diacare.18.10.1347
- By:
- Publication type:
- Article
Reduction of postprandial hyperglycemia in subjects with IDDM by intravenous infusion of AC137, a human amylin analogue.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Metabolic consequence of two-week fructose feeding in diabetic subjects.
- Published in:
- 1986
- By:
- Publication type:
- journal article
The Impact of Sulfonylurea Treatment upon the Mechanisms Responsible for the Insulin Resistance in Type II Diabetes.
- Published in:
- Diabetes Care, 1984, v. 7, p. 81
- By:
- Publication type:
- Article
The effects of oral fructose, sucrose, and glucose in subjects with reactive hypoglycemia.
- Published in:
- 1982
- By:
- Publication type:
- journal article
Increased circulating butyrate and ursodeoxycholate during probiotic intervention in humans with type 2 diabetes.
- Published in:
- BMC Microbiology, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12866-021-02415-8
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of AC137 (25,28,29 Tripro-Amylin, Human) After Intravenous Bolus and Infusion Doses in Patients with Insulin-Dependent Diabetes.
- Published in:
- 1996
- By:
- Publication type:
- Other
Pramlintide, as an Adjunct to Basal Insulin, Reduced C-Reactive Protein, Improved Glycemic Control, and Led to Weight Loss in Patients With Type 2 Diabetes.
- Published in:
- Diabetes, 2007, v. 56, p. A144
- By:
- Publication type:
- Article
Pramlintide Improved Glycemic Control and Reduced Body Weight in Patients With Type 2 Diabetes Treated With Basal Insulin (Without Mealtime Insulin) and a Thiazolidinedione.
- Published in:
- Diabetes, 2007, v. 56, p. A147
- By:
- Publication type:
- Article
Pramlintide Improved Glycemic Control and Reduced Weight Without Increased Hypoglycemia in Patients With Type 2 Diabetes Inadequately Controlled With Insulin Glargine ± Oral Agents.
- Published in:
- Diabetes, 2007, v. 56, p. A143
- By:
- Publication type:
- Article
Day-long integrated serum insulin and C-peptide profiles in patients with NIDDM. Correlation with urinary C-peptide excretion.
- Published in:
- 1988
- By:
- Publication type:
- journal article
Decreased activation of skeletal muscle glycogen synthase by mixed-meal ingestion in NIDDM.
- Published in:
- 1988
- By:
- Publication type:
- journal article
Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Effect of Pramlintide on Weight in Overweight and Obese Insulin-Treated Type 2 Diabetes Patients<sup>**</sup>.
- Published in:
- Obesity (19307381), 2004, v. 12, n. 4, p. 661, doi. 10.1038/oby.2004.76
- By:
- Publication type:
- Article
Response to Comment on Braffett et al. Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care 2019;42:657-664.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pramlintide Improved Glycemic Control and Reduced Weight in Patients With Type 2 Diabetes Using Basal Insulin.
- Published in:
- Diabetes Care, 2007, v. 30, n. 11, p. 2794, doi. 10.2337/dc07-0589
- By:
- Publication type:
- Article
Randomized Controlled Trial of a Leucine-Metformin-Sildenafil Combination (NS-0200) on Weight and Metabolic Parameters.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Effects of oral fructose in normal, diabetic, and impaired glucose tolerance subjects.
- Published in:
- 1980
- By:
- Publication type:
- journal article
41-LB: Changes in Circulating Metabolites, Including Butyrate, Points to Underlying Mechanism of a Probiotic Intervention That Improves Postprandial Hyperglycemia in Subjects with Type 2 Diabetes.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-41-LB
- By:
- Publication type:
- Article
135-OR: A Novel Thiazolidinedione (TZD) with Minimal PPAR-γ Activity Maximized for Mitochondrial Pyruvate Carrier (MPC) Modulation: Six-Month Analysis of Glycemia in a 12-Month Nonalcoholic Steatohepatitis (NASH) Study.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-135-OR
- By:
- Publication type:
- Article
758-P: Medical Food (MF) with Butyrate Producing (BP)+Mucin Regulating (MR) Microbes Improves Glucose Control (GC) in T2D.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-758-P
- By:
- Publication type:
- Article
2046-P: NS-0200 (Leucine-Metformin-Sildenafil) Reduces Weight in Obese Subjects: A 24-Week Randomized Trial.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-2046-P
- By:
- Publication type:
- Article
Evaluating the Role of Epigenetic Histone Modifications in the Metabolic Memory of Type 1 Diabetes.
- Published in:
- Diabetes, 2014, v. 63, n. 5, p. 1748, doi. 10.2337/db13-1251
- By:
- Publication type:
- Article